EV/EBITDA
2.32
NaN%
Fri, 17 Jan 2025 14:30:00 GMT
Summary
- As of February 8, 2025, SEEL EV/EBITDA is 2.32
- Over the past year, SEEL EV/EBITDA has increased by +2.90 (+500.00%).
- SEEL EV/EBITDA is now -66.81% below its all-time high of 6.99.
Performance
SEEL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SEEL EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| 1 m1 month | -0.8% | -1.0% | -92.0% |
| 3 m3 months | -2.9% | -2.9% | -97.1% |
| 6 m6 months | -13.8% | -13.9% | -99.5% |
| ytdytd | -0.8% | -0.9% | -91.4% |
| 1 y1 year | +500.0% | -54.6% | -100.0% |
| 5 y5 years | +873.3% | -35.8% | -100.0% |
SEEL EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.7% | 2.32 | at low | |
| 3 m | 3-month | 2.39 | -2.9% | 2.32 | at low |
| 6 m | 6-month | 2.95 | -21.4% | 2.32 | at low |
| 1 y | 1-year | 2.95 | -21.4% | -0.80 | +390.0% |
| 3 y | 3-year | 2.95 | -21.4% | -2.63 | +188.2% |
| 5 y | 5-year | 2.95 | -21.4% | -20.20 | +111.5% |
| alltime | all time | 6.99 | -66.8% | -20.20 | +111.5% |
Seelos Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 2.34(-454.5%) |
| 2023 | -0.66(-37.1%) |
| 2022 | -1.05(-39.7%) |
| 2021 | -1.74(-59.0%) |
| 2020 | -4.24(+748.0%) |
| 2019 | -0.50(+733.3%) |
| 2018 | -0.06(-95.3%) |
| 2017 | -1.29(-57.3%) |
| 2016 | -3.02(+874.2%) |
| 2015 | -0.31(-203.3%) |
| 2014 | 0.30(-76.0%) |
| 2013 | 1.25(+160.4%) |
| Date | Value |
|---|---|
| 2012 | 0.48(+140.0%) |
| 2011 | 0.20(-13.0%) |
| 2010 | 0.23(-105.3%) |
| 2009 | -4.35(+987.5%) |
| 2008 | -0.40(-2100.0%) |
| 2007 | 0.02(-97.4%) |
| 2006 | 0.78(-439.1%) |
| 2005 | -0.23(-560.0%) |
| 2004 | 0.05(-87.5%) |
| 2003 | 0.40(-310.5%) |
| 2002 | -0.19(-126.8%) |
| 2001 | 0.71(-74.7%) |
| 2000 | 2.81 |
FAQ
- What is Seelos Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Seelos Therapeutics?
- What is SEEL EV/EBITDA year-to-date change?
- What is Seelos Therapeutics EV/EBITDA year-on-year change?
What is Seelos Therapeutics EV/EBITDA?
The current EV/EBITDA of SEEL is 2.32
What is the all time high EV/EBITDA for Seelos Therapeutics?
Seelos Therapeutics all-time high EV/EBITDA is 6.99
What is SEEL EV/EBITDA year-to-date change?
Seelos Therapeutics EV/EBITDA has changed by -0.02 (-0.85%) since the beginning of the year
What is Seelos Therapeutics EV/EBITDA year-on-year change?
Over the past year, SEEL EV/EBITDA has changed by +2.90 (+500.00%)